# Xilio Therapeutics, Inc.: Form DEF 14A, filed Jan 26, 2026

- Company: [Xilio Therapeutics, Inc.](/companies/xlo.md) (CIK 1840233)
- Form: DEF 14A
- Filed: 2026-01-26
- Accepted by EDGAR: Jan 26, 2026, 07:30 ET
- Period: 2026-02-23
- Accession: 0001193125-26-021691
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840233/000119312526021691/xlo-20260122.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840233/000119312526021691/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840233/000119312526021691/xlo-20260122.htm

Filed Jan 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-021691. Last ingested by Listed: Nov 15, 2026, 04:19 ET. No prices; not investment advice.
